Salesforce’s VA AI deal fuels comeback hopes—and skepticism

The gist
Salesforce’s $1.6 billion VA contract rockets its AI ambitions into the federal spotlight, but investors are still torn between comeback hopes and hard skepticism.
What to know
- Salesforce landed a $1.6 billion, three-year deal with the Department of Veterans Affairs to bring AI-powered Agentforce and Missionforce platforms to 17 million veterans’ healthcare.
- The win cements Salesforce’s evolution from CRM giant to AI-driven government tech partner, building on a recent $5.6 billion Army contract and deeper public sector bets.
- Despite rapid AI subscription growth, Salesforce stock is down 56% from its peak, trading at value-stock multiples—leaving Wall Street split on whether this AI bet will pay off big.
AI Overhaul in VA Healthcare
Salesforce’s Agentforce and Missionforce are reshaping veteran care with real-time AI coordination, but face a complex road to full federal certification and integration across a vast, regulated network.
Salesforce’s deployment of AI-powered platforms such as Agentforce and Missionforce within the U.S. Department of Veterans Affairs (VA) and Veterans Health Administration (VHA) represents a tactical leap in modernizing healthcare delivery for approximately 17 million veterans. These solutions leverage real-time performance data integrated with Slack’s AI capabilities to enhance care coordination, automate alerting, and accelerate incident response across a sprawling, regulated healthcare network. As Josh Geiger, senior adviser to the VHA COO, highlights, this approach fosters a unified governance model that streamlines incident management and drives collaborative efforts to maintain facilities and improve veteran care outcomes.
The VA’s $1.6 billion, three-year Agentic Enterprise License Agreement underscores Salesforce’s strategic positioning of Agentforce and Missionforce as core infrastructure tools in one of the most demanding public healthcare environments. This contract validates Salesforce’s ability to deliver AI-driven workflow modernization in compliance-heavy, security-sensitive federal settings, reinforcing its public-sector track record. Moreover, the deal exemplifies the growing importance of agentic automation in regulated healthcare, where reliability and compliance are non-negotiable, positioning Salesforce’s platforms as foundational to AI-assisted workflows in complex government healthcare systems.
Despite the promising deployments, Salesforce’s Agentforce solution is still in its early developmental stages, facing a multi-year journey to achieve essential certifications such as FedRAMP and to meet stringent federal healthcare reliability standards. This evolution occurs amid rapid technological shifts and uncertain use cases, requiring adaptability as AI capabilities in conversation mining and integration continue to improve. Industry observers note that while AI is enhancing data extraction and workflow integration, enterprises like the VA will continue managing multiple data sources rather than a single source of truth, underscoring the complexity of tactical AI adoption in regulated healthcare.
Salesforce’s tactical AI deployments extend beyond the VA, with platforms like Agentforce Health also being adopted in other highly regulated healthcare environments such as CVS Health. This broader pattern illustrates Salesforce’s strategic approach to embedding AI solutions in complex, compliance-driven sectors, leveraging lessons from federal healthcare modernization to accelerate AI adoption across the healthcare industry. The VA contract thus not only marks a milestone in federal healthcare but also signals a scalable model for AI integration in regulated healthcare markets at large.
Salesforce’s Federal Power Play
With billion-dollar U.S. government contracts and a Swiss expansion, Salesforce is betting big on embedding AI platforms as indispensable infrastructure in high-stakes, compliance-driven sectors worldwide.
Salesforce's $1.6 billion contract with the U.S. Department of Veterans Affairs is a pivotal element of its broader federal AI strategy, following an even larger $5.6 billion, 10-year IDIQ contract with the U.S. Army announced earlier in 2026. This progression underscores Salesforce's evolution from a traditional CRM provider into a comprehensive digital transformation partner for government agencies, leveraging its Missionforce platform alongside tools like Agentforce Public Sector, Slack, MuleSoft, Data 360, and Tableau to create an integrated AI ecosystem tailored for federal modernization.
The VA deal significantly expands Salesforce's Missionforce initiative, embedding AI-driven workflow automation deeply into federal healthcare infrastructure to serve over 17 million veterans. This contract exemplifies Salesforce’s strategic focus on compliance-heavy, regulated environments, as seen in parallel expansions with entities like CVS Health, aiming to increase customer lock-in by making Agentforce and Missionforce indispensable for secure, reliable AI-assisted workflows where switching costs are high.
Complementing its federal engagements, Salesforce’s $1 billion investment in Switzerland over five years signals a deliberate international expansion of its Agentforce platform from pilot to production across diverse industries including healthcare, retail, agriculture, and global events. By anchoring itself in Switzerland—a hub for global AI governance with institutions like the International Telecommunication Union and the World Economic Forum—Salesforce is not only accelerating AI adoption but also positioning itself at the forefront of shaping regulatory frameworks beyond the U.S. government market.
Salesforce’s aggressive pursuit of large-scale federal AI contracts amid broader tech sector headwinds has reshaped investor sentiment, with its stock rising over 4% on the VA contract announcement alone. This market response reflects growing confidence in Salesforce’s multi-year government deals as a key growth driver, reinforcing its stature as a major player in the expanding U.S. government technology landscape and signaling a strategic pivot that balances commercial ambitions with public-sector modernization imperatives.
Wall Street’s Salesforce Standoff
Despite surging AI adoption and bullish analyst targets, Salesforce’s stock remains battered as investors weigh rapid product growth against stubborn doubts about sustainable AI monetization and intensifying competition.
Salesforce's stock has endured a sharp decline, plunging 56% from its all-time high and underperforming the Dow Jones with a 38% drop in 2026 alone, largely driven by investor fears of AI-driven disruption to its SaaS business despite the company’s strong earnings beats and AI product launches like Agentforce, which recently surpassed $1 billion in ARR. This bearish sentiment is reflected in widespread analyst downgrades and a consensus price target that has fallen from $348 to around $249 over the past year, signaling skepticism about Salesforce’s ability to sustain growth amid evolving AI monetization challenges and competitive pressures from players like Microsoft’s Copilot.
Despite the selloff, Salesforce appears undervalued by traditional metrics, trading at a forward P/E ratio near 11.5 to 12.5—roughly half the sector median—and a price-to-earnings-to-growth ratio well below its five-year average, suggesting a potential rebound as investors rotate from growth to value stocks. Bullish analysts like Wedbush’s Dan Ives highlight the company’s AI-driven subscription expansion and 205% year-over-year growth in Agentforce ARR, assigning a $475 price target that implies nearly 173% upside, while others caution that slower core product growth and muted customer additions temper enthusiasm, reflecting a market still grappling with the timing and scale of AI monetization.
Investor narratives are increasingly nuanced, balancing optimism about Salesforce’s strategic AI deployments—such as the transformative $1.6 billion Department of Veterans Affairs contract and Slack’s evolution into an AI-powered collaboration hub—with concerns over long-term shareholder returns, which remain negative over five years. The shift from per-seat licensing to per-action AI usage models underpins confidence in recurring revenue and margin discipline, yet key risks persist, including potential weakening of AI-driven seat usage, slower adoption of Agentforce, and intensifying competition from Microsoft. This dynamic has led to a valuation gap, with fair value estimates hovering near $255 compared to a current share price around $185, reflecting a market in flux over Salesforce’s AI growth trajectory.
Amid mixed investor sentiment, Salesforce’s aggressive capital return programs—including a $25 billion accelerated share repurchase and dividend increases—signal management’s confidence in the company’s long-term growth prospects fueled by AI adoption. Industry surveys revealing that over 60% of CIOs prefer upgrading incumbent SaaS vendors for compliance and audit capabilities bolster the narrative that Salesforce’s moat remains intact despite AI disruption fears. Comparisons with peers like ServiceNow and HubSpot, which face steeper valuation declines and AI transition uncertainties, further position Salesforce as a relatively attractive entry point for investors betting on a successful AI-driven transformation.

